Europe Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospital, Clinical Laboratory), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016 To 2021)

Europe Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospital, Clinical Laboratory), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016 To 2021)

ID: 4999 | Pages: 150 | November 2017 | Region: Europe


According to the Europe Multiplex Assays Market Research Report, the market is anticipated to grow at a 7.32% CAGR from 2016 to 2021 and it is estimated that the Europe market was valued at USD 0.67 billion in 2016 and is expected to reach USD 0.95 billion by 2021.

While multiplex bead array assays (MBAA) are widely ascribed to be a recent innovation, descriptions of these assays can be found in the literature as far back as 1977. A wide assortment of tests has been devised for MBAA using both immunological and molecular ligands. The potential advantages of these assays are apparent, such as the ability to independently and quantitatively assay multiple analytes simultaneously in small volumes of material and the collection of data from numerous beads for each ligand to provide statistical rigor. The potential cost- and time-savings that could be accrued by use of MBAA in comparison to other methods provides a strong impetus for the routine use of these in both the research and clinical laboratories. As with all clinical laboratory tests, questions of reproducibility, precision, and accuracy must be addressed in order to validate these assays. This commonly involves a comparison to methods considered to be the current standards.

Factors such as increasing number of research & development for treatment of diseases, rising adoption of multiplex assays to reduce operation costs, technological advancements, and growth in adoption of personalized medicine for increasing safety & efficacy of therapies are expected to create new opportunities for the main players during the analysis period. However, lack of experienced healthcare professionals and huge capital investments are the major restrains for the market growth.

This is can be attributed to the increase in the geriatric population, rise in the prevalence of cataract, and rise in the government initiatives to eliminate avoidable blindness. Moreover, rise in adoption of premium lens due to their enhanced visual performance ensures reduced rates of astigmatism, thus boosting the growth of the market. However, unfavorable reimbursement schemes and postoperative complications such as refractive errors are anticipated to have a negative impact on the market growth.

Europe Multiplex Assays Market Segmentation into Product, Technology, Type, Application and End User. On the basis of product, it is segmented into Consumable, Kits & Reagents and Panels. The consumables sub-segment is projected to account for the largest share of the products segment due to increase in the demand of consumables. On the basis of Technology, it is segmented into PCR and Multiplex Array. The multiplex array is further segmented into planar arrays and bead-based arrays. The multiplex arrays segment is projected to hold the largest share of the multiplex assays market. On the basis of Type, it is segmented into Nucleic Acid-Based and Protein-Based. Nucleic acid-based assays segment is further classified into planar nucleic acid assays and bead-based nucleic acid assays. Protein-based assays segment is further categorized into planar protein assays and bead-based protein assays. The protein based assays segment is expected to witness the fastest growing segment of the multiplex assays market. On the basis of Application, it is segmented into R&D and Companion Diagnostics. The research & development segment is estimated to account for the largest share of the multiplex assays market. On the basis of End User, it is segmented into Hospital and Clinical Laboratory. The pharmaceutical and biotechnology companies segment is expected to account for the largest share due to increasing adoption of multiplex assays in this segment.

Multiplex Assays Market Geography, the market is analyzed under various regions namely Germany, Spain, France, U.K. and Italy. Europe accounts for the second largest share of the market. This regional market is driven by the availability of government funds by countries like Germany, France and U.K.

Europe Multiplex Assays Industry key players are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Abcam Plc, Becton, Dickinson and Company, Luminex Corporation, Meso Scale Diagnostics, Randox Laboratories Ltd and Seegene Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Consumables         

                                5.1.3 Instruments           

                                5.1.4 Accessories             

                                5.1.5 Software and Services       

                                5.1.6  Y-o-Y Growth Analysis, By Product              

                                5.1.7  Market Attractiveness Analysis, By Product            

                                5.1.8  Market Share Analysis, By Product              

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Nucleic Acid-Based Multiplex Assays           

                                                5.2.2.1 Planar Nucleic Acid Assays

                                                5.2.2.2 Bead-Based Nucleic Acid Assays

                                5.2.3 Protein-Based Multiplex Assays    

                                                5.2.3.1 Planar Protein Assays

                                                5.2.3.2 Bead-Based Protein Assays

                                5.2.4 Y-o-Y Growth Analysis, By Type     

                                5.2.5 Market Attractiveness Analysis, By Type   

                                5.2.6 Market Share Analysis, By Type     

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Research & Development                

                                                5.3.2.1 Drug Development

                                                5.3.2.2 Biomarker Discovery and Validation

                                                5.3.3.1 Infectious Diseases

                                                5.3.3.2 Cancer

                                                5.3.3.3 Cardiac Diseases

                                                5.3.3.4 Autoimmune Diseases

                                                5.3.3.5 Alzheimer’s Disease

                                                5.3.3.6 Allergies

                                5.3.3 Companion Diagnostics     

                                5.3.4 Other Applications               

                                5.3.5 Y-o-Y Growth Analysis, By Application         

                                5.3.6 Market Attractiveness Analysis, By Application       

                                5.3.7  Market Share Analysis, By Application       

                5.4 Technology                 

                                5.4.1 Introduction           

                                5.4.2 Multiplex Pcr          

                                5.4.3 Multiplex Arrays   

                                                5.4.3.1 Multiplex Planar Arrays

                                                5.4.3.2 Multiplex Bead-Based Array

                                5.4.4 Other Technologies             

                                5.4.5 Y-o-Y Growth Analysis, By Technologies     

                                5.4.6  Market Attractiveness Analysis, By Technologies  

                                5.4.7  Market Share Analysis, By Technologies   

                5.5  End Use                      

                                5.5.1 Introduction           

                                5.5.2 Pharmaceutical & Biotechnology Companies           

                                5.5.3 Academic & Research Institutes    

                                5.5.4 Clinical Laboratories            

                                5.5.5 Hospitals  

                                5.5.6 Other End Users   

                                5.4.5 Y-o-Y Growth Analysis, By  End Use              

                                5.4.6  Market Attractiveness Analysis, By  End Use           

                                5.4.7  Market Share Analysis, By  End Use            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Type

                                                6.1.3.4 By Application

                                                6.1.3.5 By Technology

                                                6.1.3.6 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Type

                                                6.1.4.4 By Application

                                                6.1.4.5 By Technology

                                                6.1.4.6 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Type

                                                6.1.5.4 By Application

                                                6.1.5.5 By Technology

                                                6.1.5.6 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Luminex Corporation                             

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Thermo Fisher Scientific Inc.                               

                8.3 Illumina Inc.                

                8.4 Bio-Rad Laboratories Inc.                      

                8.5 QIAGEN N.V.                             

                8.6 Abcam Plc                   

                8.7 Becton                          

                8.8 Dickinson and Company                        

                8.9 Luminex Corporation                             

                8.10 Meso Scale Diagnostics                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by Product, by Application, by Technology along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the region-wise market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Multiplex Assays Market By Product, From 2016-2021 ( USD Billion )
  2. Europe Consumable Market By Region, From 2016-2021 ( USD Billion )
  3. Europe Kits & Reagents Market By Region, From 2016-2021 ( USD Billion )
  4. Europe Panels Market By Region, From 2016-2021 ( USD Billion )
  5. Europe Multiplex Assays Market By Type, From 2016-2021 ( USD Billion )
  6. Europe Nucleic Acid-Based Market By Region, From 2016-2021 ( USD Billion )
  7. Europe Protein-Based Market By Region, From 2016-2021 ( USD Billion )
  8. Europe Multiplex Assays Market By Technology, From 2016-2021 ( USD Billion )
  9. Europe PCR Market By Region, From 2016-2021 ( USD Billion )
  10. Europe Multiplex Array Market By Region, From 2016-2021 ( USD Billion )
  11. Europe Multiplex Assays Market By Application, From 2016-2021 ( USD Billion )
  12. Europe R&D Market By Region, From 2016-2021 ( USD Billion )
  13. Europe Companion Diagnostics Market By Region, From 2016-2021 ( USD Billion )
  14. Europe Multiplex Assays Market By End User, From 2016-2021 ( USD Billion )
  15. Europe Hospital Market By Region, From 2016-2021 ( USD Billion )
  16. Europe Clinical Laboratory) Market By Region, From 2016-2021 ( USD Billion )
  17. U.K. Multiplex Assays Market By Product, From 2016-2021 ( USD Billion )
  18. U.K. Multiplex Assays Market By Type, From 2016-2021 ( USD Billion )
  19. U.K. Multiplex Assays Market By Technology, From 2016-2021 ( USD Billion )
  20. U.K. Multiplex Assays Market By Application, From 2016-2021 ( USD Billion )
  21. U.K. Multiplex Assays Market By End User, From 2016-2021 ( USD Billion )
  22. Germany Multiplex Assays Market By Product, From 2016-2021 ( USD Billion )
  23. Germany Multiplex Assays Market By Type, From 2016-2021 ( USD Billion )
  24. Germany Multiplex Assays Market By Technology, From 2016-2021 ( USD Billion )
  25. Germany Multiplex Assays Market By Application, From 2016-2021 ( USD Billion )
  26. Germany Multiplex Assays Market By End User, From 2016-2021 ( USD Billion )
  27. France Multiplex Assays Market By Product, From 2016-2021 ( USD Billion )
  28. France Multiplex Assays Market By Type, From 2016-2021 ( USD Billion )
  29. France Multiplex Assays Market By Technology, From 2016-2021 ( USD Billion )
  30. France Multiplex Assays Market By Application, From 2016-2021 ( USD Billion )
  31. France Multiplex Assays Market By End User, From 2016-2021 ( USD Billion )
  32. Italy Multiplex Assays Market By Product, From 2016-2021 ( USD Billion )
  33. Italy Multiplex Assays Market By Type, From 2016-2021 ( USD Billion )
  34. Italy Multiplex Assays Market By Technology, From 2016-2021 ( USD Billion )
  35. Italy Multiplex Assays Market By Application, From 2016-2021 ( USD Billion )
  36. Italy Multiplex Assays Market By End User, From 2016-2021 ( USD Billion )
  37. Spain Multiplex Assays Market By Product, From 2016-2021 ( USD Billion )
  38. Spain Multiplex Assays Market By Type, From 2016-2021 ( USD Billion )
  39. Spain Multiplex Assays Market By Technology, From 2016-2021 ( USD Billion )
  40. Spain Multiplex Assays Market By Application, From 2016-2021 ( USD Billion )
  41. Spain Multiplex Assays Market By End User, From 2016-2021 ( USD Billion )
Middle East And Africa Lidocaine Ointment Market By Formulation (Internal Use And Topical Use), By Application (Medical, Cosmetics, And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And For...
Latin America Lidocaine Ointment Market By Formulation (Internal Use And Topical Use), By Application (Medical, Cosmetics, And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2...
Asia Pacific Lidocaine Ointment Market By Formulation (Internal Use And Topical Use), By Application (Medical, Cosmetics, And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (20...
Europe Lidocaine Ointment Market By Formulation (Internal Use And Topical Use), By Application (Medical, Cosmetics, And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2...
North America Lidocaine Ointment Market By Formulation (Internal Use And Topical Use), By Application (Medical, Cosmetics, And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2...
Lidocaine Ointment Market By Formulation (Internal Use And Topical Use), By Application (Medical, Cosmetics, And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2...
Middle East And Africa Ophthalmic Drugs Market By Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, Allergy, Uveitis, And Others), By Therapeutic Class (Anti-inflammatory Drugs, Anti-...
Latin America Ophthalmic Drugs Market By Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, Allergy, Uveitis, And Others), By Therapeutic Class (Anti-inflammatory Drugs, Anti-infective...
Asia Pacific Ophthalmic Drugs Market By Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, Allergy, Uveitis, And Others), By Therapeutic Class (Anti-inflammatory Drugs, Anti-infective ...
Europe Ophthalmic Drugs Market By Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, Allergy, Uveitis, And Others), By Therapeutic Class (Anti-inflammatory Drugs, Anti-infective Drugs,...
North America Ophthalmic Drugs Market By Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, Allergy, Uveitis, And Others), By Therapeutic Class (Anti-inflammatory Drugs, Anti-infective...
Ophthalmic Drugs Market By Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, Allergy, Uveitis, And Others), By Therapeutic Class (Anti-inflammatory Drugs, Anti-infective Drugs, Anti-g...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.